Eprontia Shortage Update: What Patients Need to Know in 2026

If you take Eprontia (Topiramate oral solution) for seizures or migraine prevention, you may have experienced difficulty filling your prescription. While Eprontia is not currently listed on the FDA's official drug shortage database, many patients report that their pharmacy doesn't carry it or can't get it quickly.

Here's what's really going on with Eprontia availability in 2026 — and what you can do about it.

Is Eprontia Still in Shortage?

As of early 2026, Eprontia is not in a formal FDA-reported drug shortage. Unlike medications that face manufacturing disruptions or raw material shortages, Eprontia's availability challenges are more about distribution and pharmacy stocking practices.

The reality is that Eprontia is a newer, brand-name specialty product. It was only approved in November 2021, and many pharmacies have never stocked it. This creates a situation that feels like a shortage to patients — even though the manufacturer (Azurity Pharmaceuticals) continues to produce and distribute the medication.

Why Is Eprontia Hard to Find?

Several factors contribute to Eprontia's limited availability:

• Low pharmacy demand: Most Topiramate prescriptions are for generic tablets, so pharmacies don't routinely order the liquid version
• Single manufacturer: Only Azurity Pharmaceuticals makes Eprontia, and no generic oral solution exists yet
• High cost: At $250–$334 for 120 mL retail, pharmacies may be reluctant to stock a product that could sit on their shelf
• Insurance barriers: Prior authorization requirements and step therapy can delay patients from picking up their prescriptions, further reducing pharmacy incentive to stock it

For a more detailed breakdown, see: Why Is Eprontia So Hard to Find?

How Much Does Eprontia Cost in 2026?

The cost of Eprontia depends on whether you have insurance and which pharmacy you use:

• Retail price (no insurance): $250–$334 for 120 mL
• With discount coupons (GoodRx, SingleCare): $85–$116 for 120 mL
• With insurance: Copay varies by plan; may require prior authorization
• Manufacturer co-pay program: Azurity offers savings through eVoucherRx and Voucher on Demand for commercially insured patients

For a complete savings guide, read: How to Save Money on Eprontia in 2026.

New Options and Developments

While Eprontia remains the only FDA-approved liquid Topiramate, patients have several alternatives if they can't access it:

• Generic Topiramate tablets: Extremely affordable (as low as $2 with coupon) and available everywhere
• Qudexy XR sprinkle capsules: Can be opened and sprinkled on food — a good option for patients who can't swallow pills
• Trokendi XR capsules: Once-daily extended-release option

There is also a generic Topiramate oral solution appearing in some pharmacy systems at around $260 for 120 mL, though availability of this generic liquid is still limited.

Learn more: Alternatives to Eprontia If You Can't Fill Your Prescription.

How to Find Eprontia in Stock

If you need Eprontia specifically, here's how to locate it:

1. Use Medfinder to check which pharmacies near you have Eprontia in stock right now
2. Try independent pharmacies — they're often more flexible with ordering specialty medications
3. Plan ahead — request your refill 7–10 days early so the pharmacy has time to order it
4. Ask your pharmacist to set up a standing order so it's automatically in stock for your next refill

For step-by-step tips, see: How to Find Eprontia in Stock Near You.

Final Thoughts

Eprontia isn't experiencing a traditional drug shortage, but it can certainly feel that way when your pharmacy doesn't have it. The limited stocking is driven by the drug's niche formulation, single-manufacturer status, and cost.

Stay proactive: use Medfinder to track availability, plan refills early, and explore alternative formulations with your doctor. Your health comes first, and there are solutions to keep your treatment on track.